Alecia M Blaszczak1, Dionisia Quiroga2, Anahita Jalilvand1, Gina S Torres Matias1, Valerie P Wright1, Joey Liu1, Lianbo Yu3, David Bradley1, Willa A Hsueh1, William E Carson4. 1. Diabetes and Metabolism Research Center, Division of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA. 2. The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Starling Loving Hall, 320 W10th Ave, Columbus, OH, 43210, USA. 3. Center for Biostatistics, The Ohio State University, 2012 Kenny Rd, Columbus, OH, 43221, USA. 4. The Ohio State University Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH, 43210, USA; Department of Surgery, The Ohio State University, 410 W 10th Ave, N911 Doan Hall, Columbus, OH, 43210, USA. Electronic address: william.carson@osumc.edu.
Abstract
BACKGROUND: Adipose tissue has emerged as an important window into cancer pathophysiology, revealing potential targets for novel therapeutic interventions. The goal of this study was to compare the breast adipose tissue (BrAT) immune milieu surrounding breast carcinoma and contralateral unaffected breast tissue obtained from the same patient. MATERIALS AND METHODS: Patients undergoing bilateral mastectomy for unilateral breast cancer were enrolled for bilateral BrAT collection at the time of operation. After BrAT was processed, adipocyte and stromal vascular fraction (SVF) gene expression was quantified by PCR. SVF cells were also processed for flow cytometric immune cell characterization. RESULTS: Twelve patients underwent bilateral mastectomy for unilateral ductal carcinoma. BrAT adipocyte CXCL2 gene expression trended higher in the tumor-affected breast as compared to the unaffected breast. Macrophage MCP-1 and PPARγ gene expression also tended to be higher in the tumor-affected breasts. T cell gene expression of FOXP3 (p = 0.0370) were significantly greater in tumor-affected breasts than unaffected breasts. Affected BrAT contained higher numbers of Th2 CD4+ cells (p = 0.0165) and eosinophils (p = 0.0095) while trending towards increased macrophage and lower Th1 CD4+ cells infiltration than tumor-affected BrAT. CONCLUSION: This preliminary study aimed to identify the immunologic environment present within BrAT and is the first to directly compare this in individual patients' tumor-associated and unaffected BrAT. These findings suggest that cancer-affected BrAT had increased levels of T cell specific FOXP3 and higher levels of anti-inflammatory/regulatory cells compared to the contralateral BrAT.
BACKGROUND: Adipose tissue has emerged as an important window into cancer pathophysiology, revealing potential targets for novel therapeutic interventions. The goal of this study was to compare the breast adipose tissue (BrAT) immune milieu surrounding breast carcinoma and contralateral unaffected breast tissue obtained from the same patient. MATERIALS AND METHODS: Patients undergoing bilateral mastectomy for unilateral breast cancer were enrolled for bilateral BrAT collection at the time of operation. After BrAT was processed, adipocyte and stromal vascular fraction (SVF) gene expression was quantified by PCR. SVF cells were also processed for flow cytometric immune cell characterization. RESULTS: Twelve patients underwent bilateral mastectomy for unilateral ductal carcinoma. BrAT adipocyte CXCL2 gene expression trended higher in the tumor-affected breast as compared to the unaffected breast. Macrophage MCP-1 and PPARγ gene expression also tended to be higher in the tumor-affected breasts. T cell gene expression of FOXP3 (p = 0.0370) were significantly greater in tumor-affected breasts than unaffected breasts. Affected BrAT contained higher numbers of Th2 CD4+ cells (p = 0.0165) and eosinophils (p = 0.0095) while trending towards increased macrophage and lower Th1 CD4+ cells infiltration than tumor-affected BrAT. CONCLUSION: This preliminary study aimed to identify the immunologic environment present within BrAT and is the first to directly compare this in individual patients' tumor-associated and unaffected BrAT. These findings suggest that cancer-affected BrAT had increased levels of T cell specific FOXP3 and higher levels of anti-inflammatory/regulatory cells compared to the contralateral BrAT.
Authors: Lore Lapeire; An Hendrix; Kathleen Lambein; Mieke Van Bockstal; Geert Braems; Rudy Van Den Broecke; Ridha Limame; Pieter Mestdagh; Jo Vandesompele; Christian Vanhove; Dawn Maynard; Camille Lehuédé; Catherine Muller; Philippe Valet; Christian P Gespach; Marc Bracke; Veronique Cocquyt; Hannelore Denys; Olivier De Wever Journal: Cancer Res Date: 2014-09-24 Impact factor: 12.701
Authors: Sabrina Johanna Fletcher; Paula Alejandra Sacca; Mercedes Pistone-Creydt; Federico Andrés Coló; María Florencia Serra; Flavia Eliana Santino; Corina Verónica Sasso; Constanza Matilde Lopez-Fontana; Rubén Walter Carón; Juan Carlos Calvo; Virginia Pistone-Creydt Journal: J Exp Clin Cancer Res Date: 2017-02-07
Authors: Saswata Talukdar; Da Young Oh; Gautam Bandyopadhyay; Dongmei Li; Jianfeng Xu; Joanne McNelis; Min Lu; Pingping Li; Qingyun Yan; Yimin Zhu; Jachelle Ofrecio; Michael Lin; Martin B Brenner; Jerrold M Olefsky Journal: Nat Med Date: 2012-09 Impact factor: 53.440
Authors: David L Morris; Kae Won Cho; Jennifer L Delproposto; Kelsie E Oatmen; Lynn M Geletka; Gabriel Martinez-Santibanez; Kanakadurga Singer; Carey N Lumeng Journal: Diabetes Date: 2013-03-14 Impact factor: 9.461